Biocryst Pharmaceuticals Inc

Analyst Insights

No matter how cynical the overall market is, Biocryst Pharmaceuticals Inc (BCRX) performance over the last week is recorded -8.17%

Sana Meer

Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) on Friday, plunged -1.34% from the previous trading day, before settling in for the closing ...

Markets

Biocryst Pharmaceuticals Inc (BCRX) EPS is poised to hit 0.04 next quarter: How Investors Can Make It Count the Most?

Steve Mayer

Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) open the trading on Wednesday, with great promise as it jumped 4.75% to $7.28, before ...

News Daemon
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.